COM:ERYTECH
PHAXIAM Therapeutics
- Stock
Last Close
0.80
28/06 15:35
Market Cap
48.66M
Beta: -
Volume Today
27.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -8.14M - | -8.86M 8.78% | -15.01M 69.45% | -21.91M 45.96% | -33.53M 53.01% | -38.22M 14.00% | -62.66M 63.93% | -73.30M 16.98% | -53.80M 26.61% | -228K 99.58% | -23.49M 10,201.75% | |
depreciation and amortization | 180.30K - | 276.52K 53.37% | 288K 4.15% | 425K 47.57% | 532K 25.18% | 797K 49.81% | 4.22M 428.98% | 4.99M 18.38% | 5.38M 7.73% | 2.91M 45.92% | 1.61M 44.70% | |
deferred income tax | -40.02K - | -1K - | 3K 400% | 2K 33.33% | 521K 25,950% | -208K 139.92% | ||||||
stock based compensation | 580.62K - | 1.24M 112.86% | 2.72M 119.76% | 1.18M 56.63% | 1.77M 50.17% | 2.45M 38.44% | 1.36M 44.51% | 1.18M 13.25% | 1.32M 12.21% | 447K 66.21% | 693K 55.03% | |
change in working capital | 1.49M - | 1.87M 25.65% | -2.62M 239.58% | 2.64M 200.96% | 3.33M 26.05% | -407K 112.23% | 13.73M 3,473.46% | 10.80M 21.33% | -7.15M 166.22% | -8.10M 13.21% | -2.07M 74.44% | |
accounts receivables | -319K - | 206K 164.58% | 142K 31.07% | 47K 66.90% | 218K - | |||||||
inventory | 32K - | 21K 34.38% | -31K 247.62% | -1.22M 3,832.26% | 1.04M 185.15% | 358K 65.51% | ||||||
accounts payables | 1.59M - | 1.16M 26.95% | 3.24M 179.57% | 8.58M 164.54% | -1.21M - | |||||||
other working capital | -3.92M - | 1.25M 132.01% | -25K 101.99% | -7.81M 31,156% | 12.69M 262.43% | 10.44M 17.71% | -8.10M - | -1.07M 86.73% | ||||
other non cash items | -541.02K - | -1.77M 226.25% | 47K 102.66% | 55K 17.02% | 3.20M 5,714.55% | -3.88M 221.48% | 45K 101.16% | 4.61M 10,133.33% | -2.52M 154.77% | -27.31M 983.03% | 4.00M 114.65% | |
net cash provided by operating activities | -6.47M - | -7.24M 11.82% | -14.58M 101.39% | -17.61M 20.83% | -24.70M 40.24% | -39.27M 58.97% | -43.31M 10.29% | -51.72M 19.42% | -56.77M 9.76% | -31.76M 44.05% | -24.37M 23.29% | |
investments in property plant and equipment | -427.40K - | -421.44K 1.39% | -269K 36.17% | -1.75M 550.93% | -1.69M 3.54% | -14.22M 742.21% | -20.13M 41.53% | -1.14M 94.33% | -298K 73.88% | -85K 71.48% | -217K 155.29% | |
acquisitions net | 16K - | 2K 87.50% | 32K - | |||||||||
purchases of investments | -3.24K - | -103 96.82% | -15K 14,463.11% | -40K 166.67% | -102K 155% | -812K 696.08% | -119K 85.34% | -421K 253.78% | -192K 54.39% | -5K 97.40% | -4K 20% | |
sales maturities of investments | 1.20K - | 5K - | 414K - | 4K 99.03% | 145K 3,525% | 586K 304.14% | 360K 38.57% | |||||
other investing activites | 142.04K - | -16K - | 81K 606.25% | 37.63M - | 388K 98.97% | |||||||
net cash used for investing activites | -288.60K - | -420.35K 45.65% | -284K 32.44% | -1.79M 528.87% | -1.79M 0.28% | -15.04M 739.59% | -19.84M 31.93% | -1.48M 92.56% | -345K 76.61% | 38.13M 11,151.30% | 171K 99.55% | |
debt repayment | -130K - | -281.34K 116.42% | -85K 69.79% | -563K 562.35% | -452K 19.72% | -818K 80.97% | -1.72M 109.78% | -1.68M 2.27% | -1.70M 1.49% | -4.63M 171.80% | -2.73M 41.09% | |
common stock issued | 15.95M - | 31.38M 96.73% | 23.61M 24.77% | 10.03M 57.51% | 177.58M 1,670.45% | 118K - | 34.63M 29,248.31% | |||||
common stock repurchased | -599.57K - | |||||||||||
dividends paid | ||||||||||||
other financing activites | -1.22M - | -1.57M 28.05% | 1K 100.06% | 1.93M 192,500% | 421K 78.14% | 1.76M - | 27.01M 1,438.04% | 11.78M 56.37% | 2.86M 75.74% | 61K 97.87% | ||
net cash used provided by financing activities | 14.00M - | 29.53M 110.97% | 23.52M 20.35% | 11.39M 51.57% | 177.54M 1,458.37% | -818K 100.46% | 40K 104.89% | 25.45M 63,522.50% | 44.71M 75.69% | -1.77M 103.95% | -3.78M 113.63% | |
effect of forex changes on cash | -1 - | -1 0% | -16K 1,599,900% | 19K 218.75% | -3.18M 16,852.63% | 3.98M 225.07% | 1.91M 52.02% | -981K 151.36% | 1.66M 268.81% | 495K 70.11% | -342K 169.09% | |
net change in cash | 7.24M - | 21.88M 202.26% | 8.65M 60.48% | -7.99M 192.39% | 147.88M 1,951.26% | -51.14M 134.58% | -61.20M 19.66% | -28.73M 53.06% | -10.75M 62.59% | 5.09M 147.36% | -28.32M 656.29% | |
cash at beginning of period | 7.88M - | 15.11M 91.90% | 36.99M 144.75% | 45.63M 23.38% | 37.65M 17.50% | 185.51M 392.79% | 134.37M 27.57% | 73.17M 45.54% | 44.45M 39.26% | 33.70M 24.18% | 38.79M 15.10% | |
cash at end of period | 15.11M - | 36.99M 144.75% | 45.63M 23.37% | 37.65M 17.50% | 185.53M 392.81% | 134.37M 27.57% | 73.17M 45.54% | 44.45M 39.26% | 33.70M 24.18% | 38.79M 15.10% | 10.47M 73.00% | |
operating cash flow | -6.47M - | -7.24M 11.82% | -14.58M 101.39% | -17.61M 20.83% | -24.70M 40.24% | -39.27M 58.97% | -43.31M 10.29% | -51.72M 19.42% | -56.77M 9.76% | -31.76M 44.05% | -24.37M 23.29% | |
capital expenditure | -427.40K - | -421.44K 1.39% | -269K 36.17% | -1.75M 550.93% | -1.69M 3.54% | -14.22M 742.21% | -20.13M 41.53% | -1.14M 94.33% | -298K 73.88% | -85K 71.48% | -217K 155.29% | |
free cash flow | -6.90M - | -7.66M 11.00% | -14.85M 93.83% | -19.36M 30.43% | -26.39M 36.28% | -53.49M 102.70% | -63.44M 18.60% | -52.86M 16.68% | -57.07M 7.96% | -31.85M 44.19% | -24.58M 22.81% |
All numbers in (except ratios and percentages)